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Abstract During the period between 2000 and 2030, the
number of persons older than 65 years is projected to grow
from 550 to 937 million worldwide. Globally, this growth
represents an increase from 6.9 to 12 %. Studies have found
that 74.6 % of women and 67.4 % of men aged 65 years or
older suffer from many clinical and subclinical syndromes
and problems, including anorexia, undernutrition, weight
loss, sarcopenia, and cachexia, which are often overlooked
or managed inadequately. These issues are very common in
the elder. The key clinical question is whether these changes
in the elder are distinct entities or an interdependent contin-
uum. In this article, we reviewed these issues of related
basic, clinical knowledge. The purpose of this review is to
enhance the recognition of anorexia, undernutrition, weight
loss, sarcopenia, and cachexia.
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In contrast to 1900, when life expectancy in industrialized
countries of the time was 45–50 years, life expectancy at
birth for the world as a whole rose to 65 years at the
beginning of the twenty-first century. This gain in longevity
is even greater for developed nations, several of which
attained life expectancy of over 80 years [74]. This demo-
graphic change is expected to have profound implications to
health care policy [11]. Elderly individuals are not only
going to continue increasing in number, but they will also
comprise a progressively larger proportion of the total pop-
ulation. During the period between 2000 and 2030, the
number of persons older than 65 years is projected to grow
from 550 to 937 million worldwide. Globally, this growth
represents an increase from 6.9 to 12 % [11]. The increased
spending to care for the elderly is anticipated to impose a
severe stress on existing medical, public health, and social
service systems. Prevalence of chronic diseases is high in
older individuals and appears to be increasing over recent
decades. Weiss et al. found that 74.6 % of women and
67.4 % of men aged 65 years or older suffer from many
clinical and subclinical syndromes and problems [89]. These
people suffer from many clinical and subclinical syndromes
and problems, including anorexia, undernutrition, weight
loss, sarcopenia, and cachexia, which are often overlooked
or managed inadequately. These issues are very common in
the elder. In this article, we reviewed these issues of related
basic, clinical knowledge. The purpose of this review is to
enhance the recognition of anorexia, undernutrition, weight
loss, sarcopenia, and cachexia.
Definition of aging
Aging has been defined as the loss of entropy and of fractality
and as the loss of homeostasis [86]. Entropy is the degree of
disorder of a system and reflects the ability of the system to
produce energy. Decreased energy production capacity entails
a progressive decline in a person’s ability to function indepen-
dently and to cope with stress. A fractal is a unit subdividing
into subunits of the same type but whose number and length
are unpredictable, similar to the branch of a tree [3, 29]. Both
structural and dynamic fractals maintain the function of the
human body. Structural fractals include the circulatory, respi-
ratory, and nervous systems. Cellular renewal is an example of
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a dynamic fractal: a few pluripotent stem cells give origin to
progressively more numerous cellular offspring with different
degrees of differentiation and maturation. The mechanisms by
which the loss of entropy and fractality occurs involve cellu-
lar, stromal, and systemic damages. Neither entropy nor frac-
tality can be assessed by clinical means. Homeostasis is the
self-regulatory ability of a system, that is the ability to come
back to basic conditions after stress. A number of parameters
become dysregulated with aging, including blood pressure,
circulating concentration of blood sugar, cortisol, and cate-
cholamine. The so-called “allostatic load” assesses the dysre-
gulation of 12 different parameters and is a useful research
tool being used for estimating the physiologic age of a person
[3, 29]. Aging is associated with increased concentration of
circulating inflammatory markers, including inflammatory
cytokines and fibrinolytic products. The concentration of
some of these substances is associated with increased risk of
death, functional dependence, and geriatric syndromes and
may mirror the functional age of the person [16, 38]. Cure
and prolongation of survival are common goals at any age. In
the case of the older person, one should add “prolongation of
active life expectancy” among the main therapeutic goals.
That means prolongation of the time during which the person
is independent and able to freely pursue his or her vital
interests (advanced activities of daily living) [34].
Aging of gastrointestinal tract
Aging of the gastrointestinal tract is less obvious than seen
in other organs, such as the brain. Most of the changes that
occur are of small magnitude and are rarely noticed unless
an excessive stress is placed on the gut. The major exception
to this seems to be the physiologic anorexia of aging that
plays a major role in weight loss with aging and makes older
persons highly vulnerable to developing cachexia [48]. It is
often difficult to distinguish true physiologic changes that
occur with aging and subclinical disease processes as is
illustrated in discussing the changes in swallowing and the
increased propensity to develop aspiration pneumonia as we
age. Another example of this physiology–disease interface
is postprandial hypotension [43].
Anorexia of aging
The concept of a physiologic anorexia of aging was first
enunciated clearly in 1988, although it had been recognized
many years ago [42, 47]. This anorexia is moremarked inmen
than in women. There is an age-related decline in appetite and
energy intake in healthy, ambulant, noninstitutionalized peo-
ple. Healthy older persons are less hungry and more full
before a meal, become more rapidly satiated after eating,
and eat fewer snacks between meals than younger persons
[13]. Average daily energy intake decreases by approximately
30 % between 20 and 80 years of age [92]. Similar study
demonstrated older people reductions in energy intake of 19 to
72 kcal/day/year in women and 25 to 100 kcal/day/year in
men, respectively, over 6 to 7 years [35]. This physiologic
anorexia involves multiple small changes, such as those in
taste and smell; altered fundal compliance; altered secretion of
gastrointestinal hormones; alterations in autonomic nervous
system feedback to the central nervous system; alterations in
the fat hormone leptin and in steroid hormones; and changes
in the central nervous system in response to food intake [42].
The physiologic reduction in appetite and energy intake has
been termed “the anorexia of aging.” The causes are not fully
understood, probably multiple, and have been reviewed else-
where. Likely, causes include increased activity of satiety
hormones, such as cholecystokinin; diminished activity of
hormones stimulating appetite, such as opioids; reduced sense
of smell and hence taste and enjoyment of food; and changes
in the gastrointestinal system that increase fullness and satiety.
Much of the human experience of taste actually is due to
the sensations produced by food in the mouth stimulating
the retronasal olfactory receptors. With aging, there is a
marked deterioration of olfactory function beginning in the
fifth decade [8]. By the age of 80 years, most individuals
have less smell identification ability than 5 to 9 years old.
Whether these changes are caused by environmental insults,
repeated viral infections, or neurodegenerative pathology is
uncertain. The four primary tastes (salt, bitter, sweet, and
sour) will decrease with aging [88]. Also, older persons lose
the increased sensitivity of the tongue tip that is seen in
younger persons [39]. Other factors, such as smoking, med-
ications, xerostomia, and local inflammatory conditions can
interfere with taste acuity. Severe zinc deficiency can lead to
loss of taste acuity. The exact effect of chemosensory dys-
function in the physiologic anorexia with aging is unknown,
but it seems to be unimportant [63]. Satiation is related to
food stretching the antrum of the stomach [43]. With aging,
the adaptive compliance of the fundus of the stomach
declines, maybe caused by decrease in nitric oxide produc-
tion in response to food. This leads to a more rapid escape of
food from fundus into antrum. Antral stretch occurs earlier,
resulting in early satiation [46, 58]. With aging in humans,
there is an increased release of cholecyctokinin (CCK),
basally and in response to fat. CCK is a more potent inhib-
itor of feeding in older persons and animals [37]. Leptin
levels increase with aging in men because of the decline in
testosterone [65]. It has been suggested that this effect of
testosterone on leptin is the reason for the increased anorex-
ia that occurs in aging men compared with women [90].
Many of the orexigenic neuropeptides, which decline with
aging, may play an important role in the anorexia with aging
[55, 57, 68, 80]. It is widely known that anorexia with aging
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makes the old people at major risk for having severe
decreases in food intake [7, 51, 87].
Undernutrition of aging
Diagnosis methods of undernutrition
There is no generally accepted gold standard method for the
diagnosis of undernutrition in older people. The Mini Nutri-
tional Assessment (MNA) [30], the Malnutrition Universal
Screening Tool [70], and the Subjective Global Assessment
[18, 31, 73] are commonly used diagnosis tools. The most
common screening tools are questions about weight loss and
the body mass index (BMI), calculated as the weight in kilo-
grams divided by height in meters squared. Appetite reduction
usually precedes weight loss. The Simplified Nutritional Ap-
petite Questionnaire comprises four questions on appetite,
timing of eating, and frequency of meals and taste and has a
high sensitivity and specificity (both >75 %) in predicting
future 5 % weight loss in older people [91]. The use of this
tool in otherwise healthy older people can identify those who
require assessment to prevent weight loss. A detailed and
further assessment by clinicians usually involves a combina-
tion of the following: anthropometric measures, questions
regarding weight loss, food intake assessment, medication
history, and measurement of blood parameters such as serum
albumin, hematocrit, lymphocyte count, total cholesterol, and
serum folate (all of which tend to be reduced in malnutrition)
[26, 83].
Prevalence of undernutrition in the old
Because there were multiple methods of assessing nutrition
and undernutrition, the relevance figures for undernutrition
among older people are significantly different. None of the
assessing methods have been universally accepted. To enable
comparisons across different settings, prevalence figures in
this review were based on widely used MNA. The reported
prevalence of nutritional risk in older people is approximately
45 % in the community, 45 to 51 % in domiciliary care
settings, 50 to 82 % in hospitals, and between 84 and 100 %
in residential care facilities [12, 17, 77–79].
Adverse effects of undernutrition
Undernutrition in older people is associated with multiple
adverse health consequences, including impaired muscle
function, decreased bone mass, immune dysfunction, anemia,
reduced cognitive function, poor wound healing, delayed
recovery from surgery, and ultimately increased mortality
[14]. Beck et al. demonstrated that subjects with better MNA
scores (MNA ≥24) had significantly lower mortality (odds
ratio 0.35, 95 % CI 0.18–0.66) than subjects at nutritional risk
(MNA <24) [6]. Older people often perceive entry into resi-
dential care as a bad outcome; individuals are at significant
risk of this following an acute illness. Acute illness (inflam-
mation) and prolonged bed rest results in increased protein
catabolism, muscle loss, and loss of physical function. Heiat et
al. investigated 908 community-dwelling elderly hospitalized
patients and demonstrated that elderly malnourished subjects
were three times more likely than nourished subjects to be
subsequently institutionalized (20.3 % MNA <17 vs 7.7 %
MNA ≥24, P<.001) [33]. Visvanathan et al. also demonstrat-
ed that undernourished (MNA <24) community-dwelling
older people in receipt of domiciliary care services were more
likely to be hospitalized and spend longer in hospital than their
nourished counterparts [84].
Management of undernutrition
When an older person presents with weight loss (partic-
ularly >5 %) or low BMI (particularly <20 kg/m2), there
is a need to complete a comprehensive assessment and
address the nonphysiologic factors. Often, these are not
addressed and therefore no improvement is noted. De-
pression, in particular, is a common cause of undernutri-
tion in the elderly. A person with depression manifesting
as weight loss is unlikely to respond well to the provi-
sion of nutritional supplements only, as this does not
address the loss of appetite, lack of motivation, and lack
of energy usually accompanying the depression. After
treating, depression is likely to result in increased oral
intake and increased willingness to participate in an
exercise and nutrition program [83].
Oral nutritional supplements such as high-energy drinks
may be beneficial, and it has been recommended that they
are taken between meals. In undernourished older people,
oral nutritional supplementation has been shown by meta-
analysis of controlled trials to produce weight gain, to be
free of side effects, and to reduce mortality by up to 34 %
among patients in short-term hospital care [41]. Although
there is no evidence to support this recommendation, there
is a general belief that multivitamin supplements are ben-
eficial in older people and they are unlikely to do harm.
Calcium and vitamin D intake should be optimized. Given
the changes in appetite and satiety, it has also been
suggested that snacking during the day may be beneficial
[1, 83].
The evidence supporting any pharmacologic agent for the
treatment of weight loss is limited [1]. Medications trialed to
date, such as megesterol acetate, dronabinol, and human
recombinant growth hormone have serious side effects es-
pecially in frail older people in whom weight loss is com-
monly seen and therefore cannot be recommended for
routine clinical use at this stage.
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Weight loss of aging
Weight loss is common in older people. It is associated with
increased morbidity and mortality, particularly when uninten-
tional, excessive (>5 % body weight), or associated with low
body weight (body mass index <22 kg/m2). Loss of body
weight or skeletal muscle mass in older persons can result
from voluntary or involuntary causes. Three primary catego-
ries of skeletal muscle loss include starvation, sarcopenia, and
cachexia [76]. Starvation is a pure protein-energy deficiency,
thus forcing a reduction in both fat and fat-free mass. The key
physiological sign of starvation is that it is reversed solely by
the replenishment of nutrients. Observed age-related decline
in muscle mass has been termed sarcopenia. Severe wasting of
both fat and fat-free mass is termed cachexia. Cachexia is
widely recognized as severe wasting accompanying disease
states such as cancer or immunodeficiency disease but does
not have a widely accepted definition. We will discuss sarco-
penia and cachexia in the latter part of this review. It is often
unrecognized, the associated adverse effects not appreciated,
and underlying causes not addressed. Intentional weight loss
by overweight older people is probably appropriate only when
functional problems have resulted from the excess weight. It is
important to include, wherever possible, exercise in weight-
loss measures to preserve skeletal muscle mass [13].
Changes in body weight
On average, people in developed countries gain weight until
they are about 50 to 60 years old, stay fairly weight stable
for a while, and then lose weight [81]. Many studies have
reported weight loss in elderly people [64]. Stevens et al.
demonstrated that women older than 85 years had BMIs
1.8 kg/m2 less than women aged 55 to 64 years and that men
older than 85 years had BMIs 2.6 kg/m2 lower than men aged
45 to 64 years, corresponding to body weights approximately
4.0 kg (9 lb) and 5.5 kg (12 lb) lower in the older adults than
the young women and men, respectively [69]. Wallace et al.
demonstrated that community-dwelling men older than
65 years lost on average 0.5 % of their body weight per year
[85]. As a result of this weight loss and the premature death of
obese people at younger ages, the prevalence of overweight
and obesity as defined by standard criteria peaks around 55 to
65 years of age and decreases after about 70 to 75 years of age
[13]. Schoenborn et al. demonstrated that four times as many
people aged 75 years and older than those aged 45 to 64 years
were underweight (BMI <18.5, 5.0 vs 1.2 %) and substantially
fewer were overweight (BMI >25, 47.2 vs 63.5 %) [64].
Adverse effects of weight loss in the old
Weight loss among the elderly is often associated with adverse
effects, particularly if the weight loss is unintentional. Ideal
weight ranges for survival are higher in older adults than in
young adults. Undernutrition, most obviously manifesting as
both low body weight and weight loss, is common in older
people and is associated with significant adverse effects.
Numerous studies have shown that weight loss in the
elderly is associated with reduced survival, certainly if the
weight loss is involuntary but possibly even when deliberate.
A study of Newman et al. demonstrated that subjects older
than 65 years, those who lost 5 % or more of their initial body
weight in the 3 years after study entry, had twice the death rate
over the following 4 years compared with the stable-weight
group. Mortality was increased with weight loss regardless of
starting weight and whether or not the weight loss was inten-
tional [50]. Somes et al. demonstrated that those who lost
1.6 kg per year or more weight had a 4.9 times greater death
rate than those without significant weight change. The adverse
association of weight loss with mortality was present even
in the subjects who were heaviest at baseline and was inde-
pendent of baseline weight [67]. Not surprisingly, uninten-
tional weight loss in older people is associated with more
adverse effects than intentional weight loss. Some studies
demonstrated increasedmortality even after intentional weight
loss in older people; it is difficult to determine what proportion
of weight loss labeled intentional was instead unintentional
[50]. Harrington et al. analyzed 26 studies examining the
connection between weight loss and mortality and demon-
strated that weight loss that was unintentional or ill defined
was associated with a significant (22–39 %) increase in mor-
tality, whereas intentional weight loss had no significant effect
on mortality [32].
An important question is whether the increased death rate
in older people who lose weight is caused by the weight loss
itself or whether the weight loss is merely a marker of under-
lying conditions that increase mortality. It is often difficult to
know, and both are likely to be true to varying degrees in
different people. In some cases, weight loss is caused by an
illness, such as a malignancy, that is mainly responsible for the
reduced survival and the weight loss is partly an innocent
bystander. There are numerous causes of pathologic anorexia
and weight loss in older people. Nevertheless, the older person
or their caregivers do not often appreciate the weight loss, and
when it is appreciated, it can trigger a search for underlying,
often treatable, causes. The weight loss and associated under-
nutrition is itself often a significant problem because weight
lost in older persons is disproportionately composed of lean
tissue, with its associated adverse effects. Consistent with this,
a reduction of mortality has been described in some groups of
older people receiving nutritional supplements [13].
Management of weight loss
Evidence suggests that weight loss is typically multifactorial.
Three common problems include starvation (or wasting),
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cachexia, and sarcopenia. It is important to identify, plan, and
implement actions to correct the causes [52]. An interdisci-
plinary approach may prove beneficial in preventing weight
loss [21]. This approach includes two approaches. The first
one is adequate nutrition: the intake of nutrition supplements
is a primary intervention [28]. Varieties of supplements are
available and provide residents with additional calories and
protein. Fortification of foods may be the most suitable way to
increase the micronutrient intake of long-term care residents
[20]. Fortifying foods allows residents to consume more
nutrients without having to increase the volume of food eaten.
The second one is feeding assistance: improvement in the
quality and adequacy of feeding assistance for mealtimes
and snacks has been shown to improve long-term care resi-
dents’ daily caloric intake and promote weight gain [66]. Use
of verbal prompting and social interactions to assist residents
to eat better is learned skills. There is little reported experience
with weight-loss drugs in older people. The lipase inhibitor
orlistat appears to be as effective in older adults but can cause
gastrointestinal side effects [81].
Sarcopenia of aging
Sarcopenia has become a core concept for understanding the
necessary course of action to maintain good function at old
age. Muscle accounts for about 40 and 75 % of body mass and
body cell mass, respectively [49]. Twenty years ago, sarcope-
nia was defined as the decline in muscle mass and function.
Sarcopenia has been most recently defined as “the age-
associated loss of skeletal muscle mass, which results in de-
creased strength and aerobic capacity and thus functional
capacity” [25]. The prevalence of sarcopenia studied in various
research studies varies significantly. Within the existing litera-
ture, the prevalence of sarcopenia in 60 to 70 years old is in the
range of 5 to 13% [44]. These prevalence estimates increase to
11 to 50 % for the population aged 80 years or older [44].
Influence of sarcopenia on physical function
Some studies have related sarcopenia to measures of functional
status, such as mobility performance, self-reported functional
limitations, and disability [4, 93]. Sarcopenia is frequently
mentioned as an important risk factor for falls in older persons.
The results of two studies are presented next, although in both
studies, the fall data were collected retrospectively; at the time
of the muscle mass assessment, the falls that occurred in the
previous 12 months were reported. Baumgartner et al. studied
the relationship of sarcopenia and falls in the past year and
reported that 22% of the men and 31% of the women reported
a fall in the past year [4]. Szulc and his colleagues also studied
the relationship between muscle mass and falls. Seven hundred
ninety-six men aged 50–85 years were included into the study.
They reported that relative appendicular muscle mass was
related to self-reported falls in the past year; 25.4 % men
reported a fall in the past year [71].
Some studies investigated the association between low
muscle mass and mortality; 1,396 men and women aged
70 years and older were included in this study. The study
showed that after adjustment for baseline age, gender, marital
status, smoking, self-rated health, ability to conduct activities
of daily living, comorbidity, cognition performance, and pres-
ence of depression, low arm muscle area was associated with
an 8-year mortality risk (hazard ratio (HR) 1.95, 95 % CI
1.25–2.00) [40]. Enoki et al. reported the relationship between
arm muscle area (square centimeter) and mortality. In multi-
variate analyses, adjusting for age, gender, functional status,
comorbidity status, and triceps skinfold thickness as a mea-
sure of body fatness, low armmuscle area was associated with
a higher mortality risk (HR 2.03, 95 % CI 1.36–3.02) com-
pared with high arm muscle area [22].
Pharmacologic treatment of sarcopenia
Sarcopenia is a complex multifactorial condition that can by
treated with multimodal methods. No pharmacologic medi-
cine to prevent or treat sarcopenia has proven to be as
efficacious as exercise (mainly resistance training) in com-
bination with nutritional intervention (adequate protein and
energy intake). This approach is currently the key strategy
for the management of sarcopenia [45]. Some new pharma-
cologic medicines may radically transfer the therapeutic
method to sarcopenia.
Testosterone levels gradually decline in elderly men at a
rate of 1 % per year. Some studies reported the relationship
between low levels of testosterone in elderly men and loss of
muscle mass, strength, and function [53]. Currently, supra-
physiologic doses of testosterone are known to dramatically
increase muscle mass and strength in young subjects
performing resistance training. In hypogonadal elderly
men, testosterone administration increased muscle mass
and muscle strength, decreased fat mass, and has been
reported to improve rehabilitation outcomes [36].
Growth hormone (GH) promotes muscle growth through
favoring the maturation of muscle satellite cells. It also indu-
ces an increase in muscular oxidative enzymes and fatigue
resistance through improving muscle mitochondrial function-
ing [60]. However, conflicting results have been reported
during GH supplementation in older people with somatopause
[72]. Other medications, which can also treat the sarcopenia,
include lepin [61], vitamin D [9], myostatin [56], and so on.
Physical therapy of sarcopenia
In considering physical training strategies for sarcopenic
subjects, physical activity can be a valuable countermeasure
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to sarcopenia in its treatment and prevention. Some studies
suggested that sarcopenia may be secondary to muscle weak-
ness in the elderly and demonstrated that muscle strength,
but not muscle mass, is independently associated with lower
extremity performance, another factor for disability among
older persons [82]. Experimental and epidemiologic data
have established that physical activity is useful for the pri-
mary and tertiary preventions of sarcopenia. It is therefore
critical to provide subjects with guidelines to ensure safe and
effective practice, just as for drug prescription. Exercise is a
medicine for chronic disease, and physicians need to pre-
scribe exercise in the same manner as they prescribe drugs
[62]. Individual or collective, indoor or outdoor, with or
without a technical support, aquatic or not—these are the
defining characteristics of physical activity. Exercise inten-
sity can be defined using subjective indicators such as a
scoring scale [54].
Cachexia of aging
Cachexia has long been recognized as a syndrome associated
with many illnesses. However, the underlying mechanisms
causing cachexia are not well understood and there is no
universally agreed upon definition. Up to now, the generally
accepted cachexia definition is that it is a complex metabolic
syndrome associatedwith underlying illness and characterized
by loss of muscle with or without loss of fat mass. The
prominent clinical feature of cachexia is weight loss in adults
(corrected for fluid retention) or growth failure in children
(excluding endocrine disorders). Anorexia, inflammation, in-
sulin resistance, and increased muscle protein breakdown are
frequently associated with wasting disease. Wasting disease is
distinct from starvation, age-related loss of muscle mass,
primary depression, malabsorption, and hyperthyroidism and
is associated with increased morbidity [23].
Cachexia is not a simple weight loss but is a complex
condition involving wasting of skeletal muscle associated
with anemia, lipolysis, insulin resistance, anorexia, and
sickness syndrome. Specific disease states are frequently
associated with cachexia. Persons with cachexia due to
cancer may deplete up to 80 % of their muscle mass [67]
More than 80 % of persons with upper gastrointestinal
cancer have cachexia at diagnosis, and more than 60 % of
lung cancer patients develop cachexia. HIV/AIDS [59],
rheumatoid arthritis [5], chronic renal insufficiency, chronic
uremia [10], and elderly persons without obvious cause [23]
have been associated with cachexia.
Cachexia is often associated with cytokine excess. Proin-
flammatory cytokines have been found in apparently
healthy older persons as a function of age. Age greater than
70 years is associated with increased circulating plasma
levels of interleukin-6 (IL-6) independent of disease states
and disorders of aging [15]. The difference in levels of IL-6
in randomly selected older persons compared with strictly
selected healthy older persons suggests that inflammatory
activity may be a marker of health status [2]. Increased
levels of circulating inflammatory components including
tumor necrosis factor-alpha, IL-6, IL-1 receptor antagonist,
soluble tumor necrosis factor receptor, C-reactive protein,
serum amyloid A, and high neutrophil counts have been
observed in older adults. These age-related changes in im-
mune function are associated with progressively increased
levels of glucocorticoids and catecholamines and decreased
growth and sex hormones, a pattern reminiscent of that seen
in chronic stress [23].
Diagnosis of cachexia
The consensus panel developed a set of diagnostic criteria
to allow clinicians and researchers to make a definitive
diagnosis of cachexia. The key component was at least a
5 % loss of edema-free body weight during the previous
12 months or less. The time frame may be disease specific
and is likely to be shorter in cancer (3–6 months) and longer
in chronic kidney or heart failure or COPD (12 months). In
cases where a history of weight loss cannot be documented,
a BMI of <20.0 kg/m2 was considered sufficient to establish
a diagnosis of cachexia. Other diagnostic criteria for cachex-
ia besides loss of muscle mass or evidence of accelerated
protein degradation in muscle are decreased muscle
strength, fatigue, anorexia, low muscle (fat-free) mass, and
biochemical abnormalities characteristic of inflammation,
anemia, or hypoalbuminemia. Ewans et al. believe that
staging of cachexia is possible and will prove useful. For
future research, Ewan et al. suggest classifying the degree of
cachexia as mild, moderate, or severe, depending on wheth-
er the observed weight loss within the previous 12 months
(or less) is >5, >10, or >15, respectively [23].
Treatment of cachexia
The treatment options for cachexia are limited. Unfortunate-
ly, refeeding a patient with cachexia does not correct the
underlying problem. Even with total parenteral nutrition,
weight stabilization does not prevent the continuing loss of
skeletal muscle mass or correct the underlying abnormality
in the metabolic state. Potential strategies for treating ca-
chexia target skeletal muscle wasting in the presence of
adequate nutrition [48]. In contrast to starvation, cachexia
is remarkably resistant to hypercaloric feeding. Pharmaco-
logical treatment of anorexia with agents that modulate
cytokine production may produce weight gain in cachexia
states [75]. Steroids and hormonal agents such as megesterol
acetate are currently widely used in the treatment of cachex-
ia and anorexia [19]. These drugs act through multiple
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pathways, such as increasing neuropeptide-Y levels to in-
crease appetite and downregulating proinflammatory cyto-
kines. Thalidomide significantly attenuated both total
weight loss and loss of lean body mass in patients with
cancer and acquired immunodeficiency syndrome [27].
Eicosapentaenoic acid can halt weight loss in cancer cachex-
ia and may increase lean body mass at high doses [24]. The
results of these pharmacological trials suggest that improve-
ment in cachexia results from a common effect of these
agents on proinflammatory cytokines.
Conclusion
Anorexia, undernutrition, weight loss, sarcopenia, and ca-
chexia in older people are very common. These issues may
be five different stages of one process. These conditions
associated with numerous adverse consequences and in-
creased morbidity and mortality, especially in undernour-
ished and weigh loss patients. These important health issues
are frequently overlooked. Clinical physician should en-
hance the recognition of anorexia, undernutrition, weight
loss, sarcopenia, and cachexia. We recommended that these
patients should take a timely, adequate, comprehensive as-
sessment and adopt measures to enable restoration of muscle
mass and strength.
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